SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is trending after the company announced a $7 billion capital raise to support massive demand from a $39 billion AI server backlog, triggering concerns about equity dilution and skepticism regarding management. Investors are actively debating whether this is a necessary move to capture long-term AI infrastructure growth or a red flag from a company with a history of governance and transparency issues.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending as investors debate the impact of upcoming DEA rescheduling hearings against the company's aggressive pivot toward an alcohol-focused strategy. The community remains deeply divided, with many expressing intense frustration over dilution and leadership performance while others point to the potential for a long-term infrastructure play in the U.S. market.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

The iShares Silver Trust (SLV) is facing intense selling pressure as a strengthening USD, surging treasury yields, and broader market volatility drive investors to liquidate precious metals positions. The community remains deeply divided, with some investors aggressively accumulating physical silver as a long-term hedge against potential inflation, while others view the recent price drop as evidence that silver has failed as a reliable store of value.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares is trending as the asset faces significant downward pressure and breaks critical technical support levels, leading to a heated community debate over whether it still functions as a safe-haven hedge. Investors are actively discussing the impact of geopolitical tensions, high interest rates, and a strengthening dollar on gold's recent underperformance.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is seeing strong investor interest driven by positive Phase 1 data for its subcutaneous BRIUMVI treatment in Myasthenia Gravis and ongoing speculation regarding a potential buyout. The community is actively discussing the company's expanding addressable market, potential acquisition targets, and the strategic positioning of its product pipeline against competitors.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors react to strong growth data for its Predictions platform, with community discussions heavily focused on the potential for massive engagement during the upcoming World Cup and the strategic advantage of operating in states where traditional sports betting remains restricted. Despite this optimism, the stock remains a subject of intense debate, as shareholders weigh the company's long-term profitability and competitive positioning against persistent frustration with management and stagnant price action over recent years.

Cracker Barrel Old Country Store, Inc. engages in the operation and development of restaurant and retail outlets. The format of its stores consists of a trademarked rustic old country-store design that offers restaurant menu featuring home-style country food. The company was founded by Dan W. Evins on September 19, 1969 and is headquartered in Lebanon, TN.

Cracker Barrel Old Country Store Inc

Cracker Barrel is seeing significant volatility as market participants debate its turnaround potential following a stronger-than-expected earnings beat and raised guidance. Investors are actively discussing the company's efforts to address declining traffic and margin pressures, with the high level of short interest fueling speculation about a potential squeeze while some remain skeptical of long-term stability.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

Serve Robotics is drawing significant market attention as it scales its physical AI delivery fleet, with community members actively discussing a potential gamma squeeze driven by heavy call option volume and high short interest. Investors remain divided on the long-term potential, weighing the company's rapid revenue growth and strategic partnerships against concerns over high cash burn and technical execution.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as investor sentiment builds ahead of an earnings release, fueled by excitement over recent patent extensions and anticipated approvals in the European market. Community discussion is focused on the stock's undervaluation, potential for a buyout, and the strong momentum leading into the company's financial update.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

Vanguard's VOO has hit a historic $1 trillion milestone, cementing its status as a cornerstone of passive investing as retail and institutional investors continue to favor broad index exposure. Community discussion remains focused on long-term wealth compounding versus short-term trading, with many investors leaning into the 'VOO and chill' strategy to navigate current market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

J&J to Expand Cancer Pipeline With $1B Firefly Bio Acquisition

JNJ is set to acquire Firefly Bio for $1 billion in cash, adding its Firelink DAC platform and advancing efforts in KRAS-driven cancer treatments.

PFE Gets FDA Nod for Expanded Use of Hemophilia Drug Hympavzi

Pfizer wins FDA approval to expand Hympavzi's use in additional hemophilia A and B patient groups, including children with inhibitors.

CORT Stock Rises 42% in a Month: Here's What You Should Know

Corcept shares surge 42% in a month as relacorilant advances in Cushing's syndrome and Lifyorli approval to expand the company's revenue base.

Here's Why Investors Should Hold on to Teladoc Health Stock for Now

TDOC gains on Integrated Care growth, international expansion and cost cuts, but BetterHelp weakness and ongoing losses remain key challenges.

ALVO Stock Gains 19% on FDA Resubmission of Biosimilar BLAs 

Alvotech shares surge after the company resubmits FDA applications for its biosimilar candidates, AVT05 and AVT06, with reviews expected within six months.

Amneal Stock Up on FDA Nod for Romidepsin Injection Solution

AMRX gains after FDA approval of ready-to-use romidepsin injection, with 180-day exclusivity and a potential boost to its injectables portfolio.

RZLT Stock on the Move: What Sparks the 38% Jump in the Past Week?

Rezolute rises 38% in a week after interim upLIFT data shows most tumor HI patients cut or eliminate IV glucose support.

Alnylam Bets on AI for Speedy RNAi Drug Discovery and Development

ALNY teams up with Inceptive in a deal worth up to $2B, using AI models and proprietary RNAi data to speed drug discovery and improve candidate selection.

Kodiak Stock Rises 35% in 3 Months: Here's What You Need to Know

KOD surges on positive phase III Zenkuda data, accelerated regulatory plans, advancing late-stage programs and a strengthened balance sheet.

SYRE Completes Enrollment in SKYWAY Basket Study on SPY072, Stock Up

Spyre Therapeutics gains after completing enrollment in all SKYWAY phase II sub-studies evaluating SPY072 across three rheumatic diseases.

Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company was founded on December 23, 2014 and is headquartered in North Chesterfield, VA.

INDVIndivior Plc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest INDV News